Noticeable strength loss struggling with things that were easy before (carrying shopping, climbing stairs)
The drugmaker said it had sent a letter to Hims on Sunday raising the infringement and demanding the telehealth company cease making these products
Semaglutide is chemically known as N-D 26 -[2-(2-[2-(2-[2-(2-[4-(17-Carboxyhepta- decanoylamino)-4(S)-carboxybutyrylamino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl] [Aib 8 ,Arg 34 ] GLP-1 -(7-37)peptide
Once the protection expires, Novo Nordisk will lose its exclusive rights to sell semaglutide-based drugs in Canada, including Ozempic and Wegovy
While some are common and manageable, others are rare and may need medical attention
Semaglutide's extended half-life enables: Sustained glycemic control : Continuous insulin secretion enhancement and glucagon suppression throughout the interdose interval Persistent appetite suppression : Ongoing central nervous system effects reducing caloric intake Convenient dosing : Once-weekly administration improving adherence compared to daily or multiple-daily injections Patients should understand that semaglutide requires several weeks to reach steady-state concentrations after each dose change (approximately 4-5 half-lives), with full clinical effects typically observed after completing the recommended dose titration schedule
